
Title: Associate Director, Finished Product and Supply Chain Operations
Reports to: Director, Drug and Finished Product Manufacturing
Location: Redwood City, California
Classification: Exempt
The Associate Director of Finished Product and Supply Chain Operations support commercial and pre‑commercial packaging component development, technology transfer, and labeling/artwork processes in addition to supply chain and inventory management with Coherus’ supply operations. This role works closely with Contract Manufacturing Organizations (CMOs), internal cross‑functional teams, and external suppliers to ensure compliant, efficient, and high‑quality manufacturing, labeling, packaging, and supply logistics operations under cGMP standards. The position is also responsible for special projects, SWAT team operations, and risk mitigation to address contract manufacturing operations matters as needed.
Responsibilities
Finished Product / Combination Product Process Development
Assembly, Labeling & Packaging Operations
Labeling / Artwork Management
Quality & Compliance
Commercial & Pre‑Commercial Supply Chain Management
Qualifications:
Required Education & Experience
Preferred Qualifications
The Base Salary Range for this position is $170,000 to $200,000. Coherus considers various factors, including professional background and work experience, when determining base pay. These considerations mean actual compensation will vary.
Coherus provides equal employment opportunities to all employees and applicants for employment and prohibits unlawful discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws. We also prohibit discrimination based on the perception that anyone has any of these characteristics or is associated with a person who has or is perceived as having any of these characteristics.

Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents.
If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.